Japanese biotechnology company CellFiber Co. has selected Philadelphia for its first international subsidiary. The expansion brings the company’s U.S. operations to University City’s growing life sciences district.
Operating as CellFiber Inc., the new subsidiary has secured space at CIC Philadelphia, located at 3675 Market Street. The property offers coworking offices and shared laboratory facilities designed to support biotechnology and life sciences companies.
Founded in Tokyo in 2015, CellFiber develops advanced cell culture and bioprocessing technologies. Its products support regenerative medicine research and the manufacturing of cell-based therapies.
The company’s technology focuses on improving the scalability of cell therapy production. Its Zeito Plus System supports the development of manufacturing processes for emerging medical treatments.
CellFiber’s Philadelphia location will serve as its primary base for entering the U.S. market. The company plans to connect with pharmaceutical manufacturers, biotechnology firms, research institutions, and contract development organizations.
Notably, CellFiber selected Philadelphia because of the region’s established cell and gene therapy industry. The city offers access to research institutions, specialized talent, and an extensive network of life sciences companies.
The expansion also highlights the importance of flexible laboratory space within Philadelphia’s commercial real estate market. Shared research facilities allow international companies to establish operations without immediately committing to large, dedicated laboratory properties.
Additionally, coworking and laboratory environments can encourage collaboration among biotechnology startups, established companies, and academic researchers.
University City remains a significant destination for healthcare research, biotechnology, and pharmaceutical innovation. Properties offering specialized laboratory infrastructure play an important role in attracting companies entering the regional market.
For Greater Philadelphia’s commercial real estate sector, CellFiber’s arrival represents another international investment in the local life sciences ecosystem. The expansion also demonstrates continued demand for flexible research and development space.
As CellFiber establishes its U.S. operations, its University City location will support connections with the region’s pharmaceutical and biotechnology industries. The move further reinforces Philadelphia’s position as a destination for international life sciences companies.
*Article courtesy of Philadelphia Business Journal
For more information about Philadelphia medical space for sale or lease or about any other properties for sale or lease, please contact WCRE at 215-799-6900.
Wolf Commercial Real Estate, a full-service CORFAC International brokerage and advisory firm, is a premier medical commercial real estate broker that provides a full range of commercial real estate listings and services, property management services, and marketing commercial offices, medical, industrial and land, retail buildings and other commercial properties for buyers, tenants, investors, and sellers.
Please visit our website for a full listing of Philadelphia commercial properties for sale or lease, www.wolfcre.com.
